Suchergebnisse - "Smith, Orla"

PubPharm (6)

1

Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients

enthalten in: JAMA | 2014

von Fowler, R. | Mittmann, N. | Geerts, W. | +126

CommentIn: Ann Intern Med. 2015 Mar 17;162(6):JC13. - PMID 25775344

2

Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequences

enthalten in: Critical care | 2013

von Cook, D. | McDonald, E. | Smith, O. | +19

3

Co-enrollment of critically ill patients into multiple studies: patterns, predictors and consequences

enthalten in: Critical care | 2013

von Cook, D. | McDonald, E. | Smith, O. | +19

4

Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis

enthalten in: Journal of critical care | 2009

von Cook, D. | Sinuff, T. | Zytaruk, N. | +63

5

Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin : an assessment of safety and pharmacodynamics: the DIRECT study

enthalten in: Archives of internal medicine | 2008

von Douketis, J. | Cook, D. | Meade, M. | +58

6

Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis : prevalence, incidence and risk factors

enthalten in: Critical care (London, England) | 2008

von Cook, D. | Douketis, J. | Meade, M. | +67

1
[1]